Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00217061
Status:
COMPLETED
Last Update Posted:
2011-05-23
First Post:
2005-09-16
Brief Title:
Effect of a Decision Aid About Statin Use in Patients With Type 2 Diabetes Mellitus
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Study Overview
Official Title:
The Statin Choice Decision Aid and Its Effects on Statin Decisions in Patients With Type 2 Diabetes Mellitus A Clustered Randomized Trial
Status:
COMPLETED
Status Verified Date:
2011-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Background- Statins are a safe and effective therapy to reduce cardiovascular risk in patients with type 2 diabetes however some patients are not prescribed statins others do not take it even after being prescribed and others stop therapy prematurely Lack of knowledge or misinformation about statins may be responsible for inadequate statin use
Objective- To test the hypothesis that a formal structured decision aid could correct deficiencies in the current decision-making process increase statin use and improve outcomes in patients with type 2 diabetes
Methods - The investigators will develop a decision aid called STATIN CHOICE and will pilot its efficacy in a blinded randomized controlled trial enrolling 98 type 2 diabetes patients
Outcomes- Primary outcomes adherence to the decision to use or not to use statins three months after using STATIN CHOICE Secondary outcomes acceptability of STATIN CHOICE knowledge about options satisfaction with decisions decisional conflict encounter duration and quality of life
Expected results- The investigators anticipate that this work will yield an effective and innovative decision aid for statin use in type 2 diabetes patients STATIN CHOICE along with a detailed users manual will be directly applicable in clinical practice Data and experience from this project will inform the planning and conduct of a randomized multicenter trial of the effectiveness of STATIN CHOICE in diverse practice settings
Significance- Patient participation in decision-making resulting in informed treatment decisions as proposed in this study will likely lead to improved quality of decision-making more appropriate use of statins and improved patient outcomes
Objective- To test the hypothesis that a formal structured decision aid could correct deficiencies in the current decision-making process increase statin use and improve outcomes in patients with type 2 diabetes
Methods - The investigators will develop a decision aid called STATIN CHOICE and will pilot its efficacy in a blinded randomized controlled trial enrolling 98 type 2 diabetes patients
Outcomes- Primary outcomes adherence to the decision to use or not to use statins three months after using STATIN CHOICE Secondary outcomes acceptability of STATIN CHOICE knowledge about options satisfaction with decisions decisional conflict encounter duration and quality of life
Expected results- The investigators anticipate that this work will yield an effective and innovative decision aid for statin use in type 2 diabetes patients STATIN CHOICE along with a detailed users manual will be directly applicable in clinical practice Data and experience from this project will inform the planning and conduct of a randomized multicenter trial of the effectiveness of STATIN CHOICE in diverse practice settings
Significance- Patient participation in decision-making resulting in informed treatment decisions as proposed in this study will likely lead to improved quality of decision-making more appropriate use of statins and improved patient outcomes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None